The Clinical Protocol Compliance/Quality Review and Data Management shared resource was first funded at the time of the CCSG renewal in 1995. This resource provides a wide range of services in support of therapeutic clinical trials, including assistance with protocol development, compliance monitoring of ongoing protocols, programs for all staff involved in the conduct of clinical research. All of these activities have expanded over the past 4 years, and with the planned start up of a Protocol Information Center (telephone services for patients and physicians calling in for RPCI clinical trial information), the development of the Community Network of Physicians who wish to enter patients on RPCI clinical trials, and the new Multicultural Program for Development of Health Care Initiatives, the major emphasis of which will be the recruitment of women and minorities to clinical trials, the renewal budget for this shared resource includes the addition of a research nurse/data manager. This person will assist new investigators in protocol development and initial data management activities of a protocol. As needed, this person will also be assigned to the other ongoing activities and the three new initiatives mentioned above which will be supported through the Protocol Office and this shared resource. RPCI is now converting to a new Hospital Information System which will significantly benefit the Protocol Office with greater efficiency, flexibility and quality of data management. This system will also enable the Protocol Office to conduct cost analyses, in real time, of ongoing clinical research, and will enable the analysis of outcomes in protocol patients versus comparable non-protocol patients. However, this conversion will be complex and time consuming. Given the long-range importance to clinical research of this conversion, and the need to maintain current database management and computer capabilities throughout the conversion process, the budget requests an increase in salary support of the Database Manager/Computer Programmer from 30 to 50%. This individual will also be involved with the set-up and maintenance of databases and computer operations for the three new initiatives mentioned above. The three positions requested through this CCSG budget are extremely important for this expanding shared resource.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016056-26S1
Application #
6588809
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-05-01
Project End
2003-04-30
Budget Start
Budget End
Support Year
26
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Wang, Xue; Niu, Jin; Li, Jun et al. (2018) Temporal Effects of Combined Birinapant and Paclitaxel on Pancreatic Cancer Cells Investigated via Large-Scale, Ion-Current-Based Quantitative Proteomics (IonStar). Mol Cell Proteomics 17:655-671
Burkard-Mandel, Lauren; O'Neill, Rachel; Colligan, Sean et al. (2018) Tumor-derived thymic stromal lymphopoietin enhances lung metastasis through an alveolar macrophage-dependent mechanism. Oncoimmunology 7:e1419115
Rosario, S R; Long, M D; Affronti, H C et al. (2018) Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas. Nat Commun 9:5330
Tsuji, Takemasa; Yoneda, Akira; Matsuzaki, Junko et al. (2018) Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy. Cancer Immunol Res 6:594-604
Narayanan, Sumana; Kawaguchi, Tsutomu; Yan, Li et al. (2018) Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer. Ann Surg Oncol 25:2323-2331
Ratajczak, Alexsandra; Feleszko, Wojciech; Smith, Danielle M et al. (2018) How close are we to definitively identifying the respiratory health effects of e-cigarettes? Expert Rev Respir Med 12:549-556
Terakawa, Tomoaki; Katsuta, Eriko; Yan, Li et al. (2018) High expression of SLCO2B1 is associated with prostate cancer recurrence after radical prostatectomy. Oncotarget 9:14207-14218
Zhu, Qianqian; Yan, Li; Liu, Qian et al. (2018) Exome chip analyses identify genes affecting mortality after HLA-matched unrelated-donor blood and marrow transplantation. Blood 131:2490-2499
Lu, Yingchang; Beeghly-Fadiel, Alicia; Wu, Lang et al. (2018) A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. Cancer Res 78:5419-5430
Li, Yanchun; Opyrchal, Mateusz; Yao, Song et al. (2018) The role of programmed death ligand-1 and tumor-infiltrating lymphocytes in breast cancer overexpressing HER2 gene. Breast Cancer Res Treat 170:293-302

Showing the most recent 10 out of 1555 publications